Literature DB >> 32498808

Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction.

Wanda Y Wu1, David W Biery2, Avinainder Singh3, Sanjay Divakaran2, Adam N Berman2, Gloria Ayuba2, Ersilia M DeFilippis4, Khurram Nasir5, James L Januzzi6, Marcelo F Di Carli7, Deepak L Bhatt8, Ron Blankstein9.   

Abstract

BACKGROUND: Left ventricular ejection fraction (EF) recovery is associated with better long-term outcomes after myocardial infarction (MI). However, the association between long-term outcomes and EF recovery among young MI patients has not been investigated.
OBJECTIVES: This study sought to evaluate the prevalence of left ventricular systolic dysfunction among patients who experience their first MI at a young age and to compare outcomes between those who recovered their EF versus those who did not.
METHODS: The YOUNG-MI registry is a retrospective cohort study of patients who experienced an MI at ≤50 years of age. EF at the time of MI and within 180 days post-MI were determined from all available medical records. The primary outcomes were all-cause and cardiovascular mortality.
RESULTS: There were 1,724 patients with baseline EF data: 503 (29%) had EF <50%, whereas 1,221 (71%) had a normal baseline EF. Patients with lower EF were more likely to have experienced ST-segment elevation MI, have higher troponin values, and have more severe angiographic coronary artery disease. Among patients with abnormal baseline EF, information on follow-up EF was available for 216, of whom 90 (42%) recovered their EF to ≥50%. Patients who experienced EF recovery had less severe angiographic disease, lower alcohol use, and a lower burden of comorbidities. Over a median follow-up of 11.1 years, EF recovery was associated with an ∼8-fold reduction in all-cause mortality (adjusted hazard ratio: 0.12; p = 0.001) and a ∼10-fold reduction in cardiovascular mortality (adjusted hazard ratio: 0.10; p = 0.025).
CONCLUSIONS: Nearly one-third of young patients presented with left ventricular dysfunction post-MI. Among them, EF recovery occurred in more than 40% and was independently associated with a substantial decrease in all-cause and cardiovascular mortality.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ejection fraction; heart failure; myocardial infarction; prevention

Mesh:

Year:  2020        PMID: 32498808      PMCID: PMC7392115          DOI: 10.1016/j.jacc.2020.03.074

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Consistency of echocardiographic ejection fraction: variation and 'drift' by interpreter and practice site.

Authors:  S Bansal; J L Vacek; D Ehler
Journal:  Eur J Echocardiogr       Date:  2002-03

2.  Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure.

Authors:  Borut Jug; Miran Sebestjen; Miso Sabovic; Irena Keber
Journal:  J Card Fail       Date:  2006-08       Impact factor: 5.712

3.  Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.

Authors:  Christophe Meune; Karim Wahbi; Yvonne Fulla; Alain Cohen-Solal; Denis Duboc; Isabelle Mahé; Guy Simoneau; Jean-François Bergmann; Simon Weber; Stéphane Mouly
Journal:  Eur J Heart Fail       Date:  2006-08-17       Impact factor: 15.534

4.  Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study.

Authors:  Anukul Ghimire; Nowell Fine; Justin A Ezekowitz; Jonathan Howlett; Erik Youngson; Finlay A McAlister
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

5.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

6.  Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.

Authors:  Gjin Ndrepepa; Julinda Mehilli; Stefan Martinoff; Markus Schwaiger; Albert Schömig; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2007-06-21       Impact factor: 24.094

7.  Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.

Authors:  Junjie Yang; David W Biery; Avinainder Singh; Sanjay Divakaran; Ersilia M DeFilippis; Wanda Y Wu; Josh Klein; Jon Hainer; Mattheus Ramsis; Pradeep Natarajan; James L Januzzi; Khurram Nasir; Deepak L Bhatt; Marcelo F Di Carli; Ron Blankstein
Journal:  Am J Med       Date:  2019-11-09       Impact factor: 4.965

8.  Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility.

Authors:  Johanna Sjöblom; Josephine Muhrbeck; Nils Witt; Mahbubul Alam; Viveka Frykman-Kull
Journal:  Circulation       Date:  2014-07-29       Impact factor: 29.690

9.  Prevalence, predictors, time course, and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction.

Authors:  Guido Parodi; Gentian Memisha; Nazario Carrabba; Umberto Signorini; Angela Migliorini; Giampaolo Cerisano; David Antoniucci
Journal:  Am J Cardiol       Date:  2007-10-24       Impact factor: 2.778

Review 10.  Stunning, hibernation, and assessment of myocardial viability.

Authors:  Paolo G Camici; Sanjay Kumak Prasad; Ornella E Rimoldi
Journal:  Circulation       Date:  2008-01-01       Impact factor: 29.690

View more
  4 in total

Review 1.  Impact of risk factors related to metabolic syndrome on acute myocardial infarction in younger patients.

Authors:  Tomomi Hasebe; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2022-06-09       Impact factor: 5.528

2.  Predictors and prognostic impact of left ventricular ejection fraction trajectories in patients with ST-segment elevation myocardial infarction.

Authors:  Zhijun Lei; Bingyu Li; Bo Li; Wenhui Peng
Journal:  Aging Clin Exp Res       Date:  2022-02-11       Impact factor: 4.481

3.  Injectable selenium-containing polymeric hydrogel formulation for effective treatment of myocardial infarction.

Authors:  Cui Yang; Chunyan Zhu; Yanling Li; Zibiao Li; Zhenghao Zhang; Jiajia Xu; Minwei Chen; Runjing Li; Shixiao Liu; Yunlong Wu; Zhengrong Huang; Caisheng Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-07-11

Review 4.  [Infarto agudo de miocardio: revisión sobre factores de riesgo, etiología, hallazgos angiográficos y desenlaces en pacientes jóvenes].

Authors:  Carlos A Dattoli-García; Cynthia N Jackson-Pedroza; Andrea L Gallardo-Grajeda; Rodrigo Gopar-Nieto; Diego Araiza-Garygordobil; Alexandra Arias-Mendoza
Journal:  Arch Cardiol Mex       Date:  2021-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.